DJIA 17,042.90 -28.32 -0.17%
NASDAQ 4,493.39 0.00 0.00%
S&P 500 1,972.29 -5.51 -0.28%
market minute promo

Seattle Genetics (NASDAQ: SGEN)

37.18 -1.21 (-3.15%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SGEN $37.18 -3.15%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $37.02
Previous Close $38.39
Daily Range $36.26 - $37.62
52-Week Range $32.35 - $55.99
Market Cap $4.6B
P/E Ratio -63.98
Dividend (Yield) $0.00 (0.0%)
Volume 2,164,781
Average Daily Volume 847,404
Current FY EPS -$0.82

Sector

Healthcare

Industry

Drugs

Seattle Genetics (SGEN) Description

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Website: http://www.seattlegenetics.com/

News & Commentary Rss Feed

Are Investors Wrong About Celldex Therapeutics?

Short-sellers have been pushing into Celldex Therapeutics this year. Here's why.

Will This Analyst Downgrade Hurt Seattle Genetics (SGEN) Stock Today?

Benzinga's Top Downgrades

Bank of America Downgrades Seattle Genetics To Underperform

Weak On High Volume: Seattle Genetics (SGEN)

Seattle Genetics Seeks Expanded Use of Lymphoma Drug Following Study Win

Sector Update: Health-Care Shares Sink in Pre-Market Trade

Sector Update: Health Care

Seattle Genetics' Adcetris Positive in Durability Analysis - Analyst Blog

Seattle Genetics' Adcetris Positive in Durability Analysis - Analyst Blog

Interesting SGEN Put And Call Options For November 22nd

Seattle Genetics Offers Updated Progression-Free Survival, Overall Survival Data from ADCETRIS Front

Seattle Genetics Offers Updated Progression-Free Survival, Overall Survival Data from ADCETRIS Frontline PTCL Phase 1 Trial

See More SGEN News...

SGEN's Top Competitors

SGEN $37.18 (-3.15%)
Current stock: SGEN
AMGN $140.46 (0.28%)
Current stock: AMGN
GILD $106.45 (-0.99%)
Current stock: GILD
BIIB $330.81 (0.20%)
Current stock: BIIB